» Articles » PMID: 37386007

Ferroptosis and the Bidirectional Regulatory Factor P53

Overview
Date 2023 Jun 29
PMID 37386007
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a type of regulated cell death characterized by iron-mediated lipid peroxidation, in contrast with apoptosis, autophagy, and necrosis. It can be triggered by many pathological processes, including cellular metabolism, tumors, neurodegenerative diseases, cardiovascular diseases, and ischemia-reperfusion injuries. In recent years, ferroptosis has been discovered to be associated with p53. P53 is a tumor suppressor protein with multiple and powerful functions in cell cycle arrest, senescence, cell death, repair of DNA damage, and mitophagy. Emerging evidence shows that ferroptosis plays a crucial role in tumor suppression by p53. P53 functions as a key bidirectional regulator of ferroptosis by adjusting metabolism of iron, lipids, glutathione peroxidase 4, reactive oxygen species, and amino acids via a canonical pathway. In addition, a noncanonical pathway of p53 that regulates ferroptosis has been discovered in recent years. The specific details require to be further clarified. These mechanisms provide new ideas for clinical applications, and translational studies of ferroptosis have been performed to treat various diseases.

Citing Articles

Artesunate Inhibits the Proliferation and Migration of Cutaneous Squamous Cell Carcinoma by Regulating the SLC7A11-GPX4 Pathway via the p300-p53 Axis.

Huang X, Wang W, Zhang S, Li L, Huang J Biomol Ther (Seoul). 2025; 33(2):365-377.

PMID: 39989046 PMC: 11893488. DOI: 10.4062/biomolther.2024.156.


Ferroptosis in thyroid cancer: mechanisms, current status, and treatment.

Tian W, Su X, Hu C, Chen D, Li P Front Oncol. 2025; 15:1495617.

PMID: 39917169 PMC: 11798778. DOI: 10.3389/fonc.2025.1495617.


Neuronal Injury after Ischemic Stroke: Mechanisms of Crosstalk Involving Necroptosis.

Zhang X, Li H, Zhao Y, Zhao T, Wang Z, Tang Q J Mol Neurosci. 2025; 75(1):15.

PMID: 39903429 DOI: 10.1007/s12031-025-02313-y.


Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy.

Ajam-Hosseini M, Babashah S Mol Cell Biochem. 2025; .

PMID: 39869280 DOI: 10.1007/s11010-024-05169-9.


Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.

Imam M, Ji J, Zhang Z, Yan S Front Pharmacol. 2025; 15:1493188.

PMID: 39867656 PMC: 11757020. DOI: 10.3389/fphar.2024.1493188.


References
1.
Liu X, Chen C, Han D, Zhou W, Cui Y, Tang X . SLC7A11/GPX4 Inactivation-Mediated Ferroptosis Contributes to the Pathogenesis of Triptolide-Induced Cardiotoxicity. Oxid Med Cell Longev. 2022; 2022:3192607. PMC: 9225845. DOI: 10.1155/2022/3192607. View

2.
Mancias J, Wang X, Gygi S, Harper J, Kimmelman A . Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509(7498):105-9. PMC: 4180099. DOI: 10.1038/nature13148. View

3.
Ashraf A, Jeandriens J, Parkes H, So P . Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis. Redox Biol. 2020; 32:101494. PMC: 7083890. DOI: 10.1016/j.redox.2020.101494. View

4.
Gao M, Monian P, Quadri N, Ramasamy R, Jiang X . Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015; 59(2):298-308. PMC: 4506736. DOI: 10.1016/j.molcel.2015.06.011. View

5.
Tarangelo A, Rodencal J, Kim J, Magtanong L, Long J, Dixon S . Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity. Life Sci Alliance. 2022; 5(4). PMC: 8807879. DOI: 10.26508/lsa.202101157. View